Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.

MLA

Mohammadi, Homan, et al. “Isocitrate Dehydrogenase 1 Mutant Glioblastomas Demonstrate a Decreased Rate of Pseudoprogression: A Multi-Institutional Experience.” Neuro-Oncology Practice, vol. 7, no. 2, Mar. 2020, pp. 185–95. EBSCOhost, https://doi.org/10.1093/nop/npz050.

APA

Mohammadi, H., Shiue, K., Grass, G. D., Verma, V., Engellandt, K., Daubner, D., Schackert, G., Gondim, M. J., Gondim, D., Vortmeyer, A. O., Kamer, A. P., Jin, W., Robinson, T. J., Watson, G., Yu, H.-H. M., & Lautenschlaeger, T. (2020). Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience. Neuro-Oncology Practice, 7(2), 185–195. https://doi.org/10.1093/nop/npz050

Chicago

Mohammadi, Homan, Kevin Shiue, G Daniel Grass, Vivek Verma, Kay Engellandt, Dirk Daubner, Gabriele Schackert, et al. 2020. “Isocitrate Dehydrogenase 1 Mutant Glioblastomas Demonstrate a Decreased Rate of Pseudoprogression: A Multi-Institutional Experience.” Neuro-Oncology Practice 7 (2): 185–95. doi:10.1093/nop/npz050.